Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
E-pub ahead of print

Frequency and Impact of Hyponatremia on All-Cause Mortality in Patients with Aortic Stenosis

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. A method for modelling the oxyhaemoglobin dissociation curve at the level of the cerebral capillary in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Ventilation-perfusion SPECT versus CTPA in young adult females with suspected pulmonary embolism

    Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiForskningpeer review

  3. High low-density lipoprotein levels and high risk of aortic stenosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Emilie Ramberg
  • Anders M Greve
  • Ronan M G Berg
  • Ahmad Sajadieh
  • Steen Bendix Haugaard
  • Ronnie Willenheimer
  • Michael H Olsen
  • Kristian Wachtell
  • Olav W Nielsen
Vis graf over relationer

Asymptomatic aortic stenosis (AS) is a frequent condition that may cause hyponatremia due to neurohumoral activation. We examined if hyponatremia heralds poor prognosis in patients with asymptomatic AS, and whether AS in itself is associated with increased risk of hyponatremia. The study question was investigated in 1,677 individuals that had and annual plasma sodium measurements in the SEAS (Simvastatin and Ezetimibe in AS) trial; 1,873 asymptomatic patients with mild-moderate AS (maximal transaortic velocity 2.5 to 4.0 m/s) randomized to simvastatin/ezetimibe combination versus placebo. All-cause mortality was the primary endpoint and incident hyponatremia (P-Na + <137 mmol/L) a secondary outcome. At baseline, 4% (n = 67) had hyponatremia. After a median follow-up of 4.3 (interquartile range 4.1 to 4.6) years, 140 (9%) of those with initial normonatremia had developed hyponatremia, and 174 (10%) had died. In multiple regression Cox models, both baseline hyponatremia (hazard ratio [HR] 2.1, [95% confidence interval 1.1 to 3.8]) and incident hyponatremia (HR 1.9, [95% confidence interval 1.0 to 3.4], both p ≤ .03) was associated with higher all-cause mortality as compared with normonatremia. This association persisted after adjustment for diuretics as a time-varying covariate. Higher N-terminal pro b-type natriuretic peptide levels and lower sodium levels at baseline was associated with higher risk of incident hyponatremia. Conversely, assignment to simvastatin/ezetimibe protected against incident hyponatremia. In conclusion, both prevalent and incident hyponatremia associate with increased mortality in patients with AS. The prevalence of hyponatremia is around 4% and the incidence about 2% per year, which is comparable to that of older adults without AS.

TidsskriftThe American journal of cardiology
StatusE-pub ahead of print - 19 nov. 2020

ID: 61308060